suggested that this enzyme may play a role in blood pressure regulation. We previously reported that the expression levels of Comt mRNA in Dahl salt-sensitive (DS) rats were lower than those in Lewis (LEW) rats. 
Introduction
Dahl salt-sensitive (DS) rats have been widely used for investigation of salt-sensitive hypertension. More than 16 genomic regions for blood pressure (BP) regulation have been reported in this strain. However, most of the genes responsible for this salt-sensitive hypertension have not yet been confirmed (1) (2) (3) .
We previously found that the expression levels of Comt mRNA in the kidneys of DS rats were lower than those in Lewis (LEW) rats (4) . However, the physiological significance of this phenomenon has not been investigated.
Catechol-O-methyltransferase (COMT) is an enzyme which inactivates catecholamines, including dopamine (DA) and norepinephrine (NE). This enzyme is expressed in various tissues of the rat (5) , with the liver showing the highest enzyme activity (6) . Several studies have suggested that this enzyme may play a role in BP regulation. Spontaneously hypertensive rats (SHR) have been reported to have lower activities and less membrane-bound COMT (MB-COMT) than Wistar-Kyoto (WKY) rats (7, 8) . In humans, entacapone, a selective COMT inhibitor, has been reported to increase BP dose-dependently (9) . Although these reports suggest that the inhibition of COMT may induce higher BP, mice in which the Comt gene has been disrupted have been reported to be resistant to salt-induced hypertension (10) . A natriuretic effect of COMT inhibition has also been demonstrated in rats treated with nitecapone (11) or entacapone (12) . Indeed, in our previous F2 analysis, a Dahl-type Comt locus genotype was nominally associated with lower BP levels (4) . The purpose of the present study was to extend our previous study and more precisely evaluate the significance of Comt in Dahl salt-sensitive hypertension.
Methods

Northern Blotting
Twelve-week-old DS and LEW rats (n= 4 each) were obtained from Japan SLC (Shizuoka, Japan) and Oriental Yeast (Tokyo, Japan), respectively. Total RNA samples were prepared from various tissues including the kidneys, adrenal glands, livers and brains, using TRIzol reagent (Invitrogen, Carlsbad, USA). Poly(A) + RNA was purified from total RNA using oligotex-dT30<Super> (TaKaRa Shuzo, Shiga, Japan). Aliquots of poly(A) + RNA (1 μg) were separated by 1% denatured agarose gel electrophoresis and transferred to a ZetaProbe membrane (Bio-Rad, Hercules, USA). After prehybridization for 1 h at 65°C, the membranes were subjected to hybridization for 16 h at the same temperature and in the same solution containing 32 P-labeled Comt or Gapdh cDNA fragments as probes. The cDNA fragment was prepared by reverse transcription (RT)-polymerase chain reaction (PCR) with the following amplimers: Comt-S, 5′-tggtttgagtacgtgctg ca; Comt-A, 5′-atctccatggtgagaagcct; Gapdh-S, 5′-ccactcaga agactgtgga; Gapdh-A, 5′-cctctctcttgctctcagta; and then labeled using a Prime-It II Random Primer Labeling Kit (Stratagene, La Jolla, USA). After hybridization, the membranes were washed twice (5 min each time) at room temperature with 2× SSC and 0.1% SDS, and then twice (30 min each time) at 60°C with 1× SSC and 0.1% SDS. Hybridized signals were detected and quantified by a BAS-2500 imaging system (Fuji Film, Tokyo, Japan).
Western Blotting
Anti-COMT monoclonal antibody and anti-actin polyclonal antibody were obtained from BD Transduction Laboratories (San Diego, USA) and Santa Cruz Biotech (Santa Cruz, USA), respectively. Kidneys from LEW and DS rats (12 weeks old; n= 4) were homogenized in 250 mmol/L Tris-HCl (pH 7.4) and centrifuged at 1,000 rpm and 4°C for 10 min. The protein concentration of the post nuclear fraction was determined using a BCA Protein Assay Kit (Pierce, Rockford, USA). Equal amounts of proteins (20 μg) were separated by SDS-PAGE (10%) and transferred to a nitrocellulose membrane (Pall Corporation, East Hills, USA). After being blocked with 5% BSA, membranes were incubated with primary antibody (1:10,000 dilution) at room temperature for 1 h, and membrane-bound antibodies were visualized by horseradish peroxidase-conjugated secondary antibodies (1:10,000 dilution; 1 h) and an ECL system (Amersham Biosciences, Piscataway, USA). The expression levels were determined by densitometry.
Sequencing Analysis of the Rat Comt Gene
Genomic DNAs were extracted from the livers of DS and LEW rats using proteinase K and phenol (13) . The entire sequences of the promoter region and all of the 7 exon regions, including the non-coding regions (exons 5-7), of Comt of DS and LEW rats were determined. The primers used for the sequencing are shown in Table 1 .
Sequence analyses revealed that an insertion (212 bps) was present in exon 4 in DS rats. The sequence of this insertion was palindromic. The secondary structure was predicted using Genetyx software version 8 (Genetyx, Tokyo, Japan). 
Construction of Reporter Plasmids and Reporter Analysis
To evaluate the possible effect of the 3′-untranslated region (3′-UTR) of the Comt mRNA on its mRNA stability, the 3′-UTRs of the Comt mRNA from DS and LEW rats were subcloned into the 3′-UTR region of the luciferase expression vector. The 3′-ends of Comt mRNA in the kidneys of DS and LEW rats were determined using the 3′RACE System for the Rapid Amplification of cDNA Ends Kit (Invitrogen) and the following primers: Comt-3RACE-F1, 5′-gtagacggcttggagaaggc; and Comt-3RACE-F2, 5′-gtcttgatccctcagcctgc. We subcloned the 3′-UTRs of Comt mRNA from DS and LEW rats into the EcoRI site of the pAcGFP1-C1 vector (BD Biosciences Clontech, Palo Alto, USA) in a forward direction. The 3′-UTR region was amplified by Comt-3UTR-A (5′-atc caaatatgtagatctttaatttct), which corresponded to the 3′-terminal region of Comt mRNA, and by Comt-3RACE-F2. Madin-Darby canine kidney (MDCK) cells were cultured in Dulbecco's modified Eagle medium (DMEM) with 10% fetal calf serum and transiently cotransfected with the above reporter plasmids, pGL3-control (Promega, Madison, USA) and phRL-SV40 vector (Promega) by the Lipofectamine2000 reagent (Invitrogen). After being incubated for 24 h, the cells were washed with 1× PBS and then used for the following experiments. First, to compare the amounts of AcGFP expression constructs in transfected cells, total DNA samples were prepared using a DNeasy Tissue Kit (QIAGEN, Hilden, Germany). The DNA level of AcGFP was analyzed by PCR analysis using the primers AcGFP-S (5′-cctgatcgagctgaatggcg) and AcGFP-A (5′-tgctggtagtggtcggccag), with 18S ribosomal DNA as a control (QuantumRNA 18S Internal Standards Kit; Ambion, Austin, USA). Second, to compare the mRNA decay rate among the transfectants, actinomycin D (Nacalai Tesque, Kyoto, Japan) (5 μg/mL) was added to the culture medium and cells were incubated for varying lengths of time (up to 6 h). Total RNA samples were isolated from these cells using an RNeasy Mini Kit (QIAGEN) according to the manufacturer's protocol. RT-PCR was carried out with the following amplimers: the primer pair for AcGFP described above and Luc-S (5′-cgttatttatcggagttgcagttg) and Luc-A (5′-aagaag gagaatagggttggcac). The intensity of the PCR product from the AcGFP reporter constructs relative to that of the PCR product from the pGL3-control vector was assessed by a densitometer. Third, to measure the fluorescence intensity of AcGFP expressed in the transfectants, cells were lysed using Triton-based lysis buffer (1% Triton X-100, 20 mmol/L Tris, pH 7.4, 150 mmol/L NaCl, 1 mmol/L EDTA, 1 mmol/L EGTA, 2.5 mmol/L sodium pyrophosphate, 1 mmol/L β-glycerol phosphate, 1 mmol/L Na3VO4, 1 μg/mL leupeptin, and a 0.1% protease inhibitor mixture [Nacalai Tesque]). The fluorescence intensity of AcGFP was then measured using a 1420 ARVO-HTS system (PerkinElmer, Wellesley, USA) (excitation: 485 nm; emission: 535 nm). Fourth, luciferase activity in these transfectants was also determined using a Dual-Luciferase Reporter Assay System (Promega) according to the manufacturer's protocol.
Genotyping of F2 Rats
The details of F2 analysis have been described previously (1) . Briefly, male DS rats were mated with female LEW rats to produce F1 rats, and F1 rats were then intercrossed to produce an F2 population consisting of 107 male rats. F2 rats were started on an 8% NaCl diet (Oriental Yeast, Tokyo, Japan) at 5 weeks of age according to the protocol described by Rapp et al. (3) . Radiotelemetry devices (Data Sciences International, Arden Hills, USA) were implanted into the lower abdominal aorta of F2 rats at 9 weeks of age using sodium pentobarbital as an anesthetic agent (25 mg/kg, i.p.). At 14 weeks of age, BP and heart rate were continuously measured for 44 h (daytime 7:00 AM to 7:00 PM; nighttime 7:00 PM to 7:00 AM), and the data obtained during the latter 24 h were used for analyses. The results were analyzed using Fluclet TM software (Dainippon Pharmaceutical, Osaka, Japan) (14) .
Genotyping was performed by PCR using appropriate PCR primer pairs (custom-made by Amersham Pharmacia Biotech, Piscataway, USA), based on information from the Rat Genome Database (http://rgd.mcw.edu/) and Ratmap (http:// ratmap.gen.gu.se/). We found sequence variations between DS and LEW rats in several genes, and these polymorphisms were also included in the genotyping data. Genotyping of Comt was performed by PCR-electrophoresis using the primer pair E4S2 and E4A2 (Table 1) . We separately analyzed quantitative trait loci (QTLs) for daytime systolic BP (D-SBP), daytime diastolic BP (D-DBP), nighttime systolic BP (N-SBP), nighttime diastolic BP (N-DBP), and pulse pressure (PP) levels using MapManager QTLb20.6 (15) . We performed Quick Test to obtain significant thresholds for the BP and PP values. The likelihood ratio statistics (LRSs) for suggestive, significant, and highly significant loci were calculated to be 12.2, 17.7, and 25.9, respectively.
Microarray Analysis
Male DS and LEW rats (n= 3 each) were fed an 8% NaCl diet starting at 5 weeks of age for 8 weeks. Total RNA was isolated from DS and LEW kidneys with TRIzol reagent (Invitrogen), and subjected to microarray analysis. Procedures for the microarray analysis were essentially identical to those reported previously (16) . The rat genome GeneChip ® Rat Genome 230 2.0 arrays were used in the present study. The resulting data were analyzed with GeneChip Operating Software (Affymetrix, Santa Clara, USA). Three independent experiments were performed to compare expression levels of mRNAs between the kidneys of salt-loaded DS and saltloaded LEW rats (the raw data have been submitted to NCBI http://www.ncbi.nih.gov/geo/; GEO accession number: GSE4800). We selected genes whose expression levels were modulated more than 2-fold or less than 0.5-fold in all three independent assessments. Genes with expression levels below 100 in both strains were excluded due to unreliability. We then selected genes that were localized to the chromosome (Ch)11 QTL region.
Effects of COMT Inhibitors on BP Levels
The effect of oral administration of COMT inhibitors on BP levels was studied in the DS and LEW rats on a high salt diet (8% NaCl). Male DS rats at 8 weeks of age were randomly divided into two groups: the COMT inhibitor-treated group (n= 3, a high salt diet and the COMT inhibitor) and the control group (n= 3, a high salt diet only). Radiotelemtery devices were implanted into the lower abdominal aorta of DS rats at 9 weeks of age. Rats were allowed 1 week of recovery from surgery. Both oral administration of COMT inhibitor and salt loading were started at 11 weeks of age. The COMT inhibitor-treated group received 3,5-dinitrocatechol (17) suspended in water (30 mg/kg body weight) by gastric gavage every 48 h for 18 days. The control group was given the same amount of water as vehicle (0.5 mL/100 g body weight). The identical protocol was applied to the LEW rats (n= 3 in the COMT-treated group, n= 4 in the control group) under a high salt diet (8% NaCl) using the same dose (30 mg/kg body weight/48 h).
All the statistical analyses were performed using the JMP statistical package (SAS Institute, Cary, USA). Differences in BP over time between the control and treatment groups were evaluated by MANOVA.
The present study was conducted in accordance with the current guidelines for the care and use of experimental animals of the National Cardiovascular Center.
Results
Confirmation of the Differential Expression of Comt
The expression levels of Comt mRNA in the kidneys and adrenal glands from DS and LEW rats were determined by Northern blotting (Fig. 1A) . The expression levels of Comt mRNA in DS kidneys were 2-fold lower than those in LEW kidneys (p= 0.0002) (Fig. 1B) . COMT protein levels were also lower in DS kidneys than in LEW kidneys (p= 0.0116) (Fig. 2) . Comt mRNA in DS rats appeared to be longer than that in LEW rats. RT-PCR analysis indicated that expression levels of Comt mRNA in livers, adrenal glands and brains were significantly lower in DS than in LEW rats (data not shown).
Sequencing and 3′-End Analyses of Comt
Sequence analysis of Comt in DS and LEW rats identified 10 polymorphisms (Fig. 3) . Of these, 7 polymorphisms were t  c  c  a  a  t  a  t  t  g  a  a  a  a  a  a  a  t  t  t  t  c  a  t  a  a  a  g  a  t  g  c  a  t  a  g  a  a  c  c  t  t  g  a  g  t  g  a  a  t  a  c  a   C  G  G  A  A  C  G  C  G  A  A  C  G  A  T  C  C  G  T  T  C  G  C  G  A  G  A  T  G  G  T  G  A  C  T  C  G  A  T  T  T  A  G  G  G  G  T  T  G  G  G  G  T   T  T  C  T  C  T  C  T  A  T  T  G  A  A  A  A  A  A  A  A  A  A  A  A  A  A  A  A  A  G  G  C  C  T  C  G  A  C  C  C  C  T  G  G  C  T  T  G  G  G  T  C  C   C  C  G  G  G  A  C  C  C  A  A  G  C  C  A  G  G  G  G  T  C  G  A  G  G  C  T  T  T  T  T  T  T  C  T  T  G  G  T  T  T  T  T  T  T  T  T  T  T  T  T  T  T   T  C  C  A  A  C  C  C  C  G  A  C  C  C  C  T  A  A  A  T  C  G  A  G  T  C  A  C  C  A  T  C  T  C  G  C  G  A  A  T  G  G  A  T  C  C  T  T  C  G  C  T identified in the region corresponding to the 3′-UTR in exon 4 (Fig. 3B) . No polymorphisms were detected in the promoter region sequenced (up to −1 kb). Intriguingly, a 212-bp palindromic fragment was inserted near the 3′-end of exon 4 in DS rats. The entire sequence of this insertion is shown in Fig. 4A . The computational prediction of the secondary structure indi- cated the existence of a stable and tight stem-loop structure (Fig. 4B) . The 3′RACE revealed that exon 4 was the end of Comt mRNA in DS and LEW kidneys, and the insertion appears to be the reason for the longer mRNA in DS rats detected by Northern blotting.
Fig. 4. Entire sequences of a 212-bp insertion and the secondary structure prediction of its transcript. A 212-bp palindromic fragment was inserted in the 3′ end of exon 4 in the DS Comt gene. A: The entire sequences of this insertion are shown. B: The secondary structure of its transcript was predicted using Genetyx software version 8. The computational prediction indicated the existence of a stable and tight stem-loop structure.
Effect of 3′-UTR on the Differential Expression of Comt in DS and LEW Rats
To examine whether the insertion in exon 4 is responsible for the reduced expression of Comt mRNA in DS kidneys, we constructed reporter vectors (AcGFP expression vectors) with either DS or LEW 3′-UTR, and then transfected MDCK cells with these reporter constructs. At 24 h after transfection, the DNA level of the transgene was not significantly different among the transfectants (Fig. 5A) . Next, to clarify whether the mRNA decay rate is enhanced in DS-type transfectants, we examined the rate of AcGFP mRNA decay after the inhibition of RNA polymerase II-dependent transcription by actinomycin D (Act D) (18) . The AcGFP-DS-type 3′-UTR mRNA exhibited a faster decay than both the control AcGFP and AcGFP-LEW-type 3′-UTR mRNA (Fig. 5B) . Moreover, the cells were observed by fluorescence microscopy after transfection (Fig. 5C) , and the fluorescence intensity of AcGFP and luciferase activity in these transfectants were then measured. The relative fluorescence intensity of AcGFP per luciferase activity in the DS-type transfectants was significantly decreased relative to that in LEW-type transfectants (p= 0.0014) (Fig. 5D) . Similar results were obtained by Western blotting using AcGFP-specific antibody (Clontech) (data not shown). These findings indicate that DS-type Comt-3′-UTR decreases the stability of its mRNA, leading to a reduction of the protein level.
QTL Analyses for BP and PP
We previously performed analyses to determine the QTL region that influenced BP using an F2 cohort from DS and LEW rats (1) . In the present study, we newly determined the genotype of Comt in 107 F2 rats by PCR based on insertion of a 212-bp sequence. Marker regression analysis indicated that the Ch11 Comt region was not significantly associated with any of the 4 BP values (below a suggestive LRS=12.2). However, the Comt genotype was nominally associated with systolic blood pressure (SBP) values, but not with diastolic blood pressure (DBP) values (Table 2) . Intriguingly, QTL analysis indicated that the Comt locus corresponds to a significant locus for PP (Fig. 6) . PP values of F2 rats with the DS genotype were lower than those of F2 rats with the LEW genotype ( Table 2) .
Identification of Differentially Expressed Genes
We performed microarray analyses using RNA samples from DS and LEW kidneys. Within the Ch11 QTL region for PP, Comt was the only gene that was differentially expressed between DS and LEW kidneys (Table 3) . Microarray analyses in the Dahl salt-sensitive (DS) and Lewis (LEW) kidneys identified 2 differentially expressed genes on the Ch11. Comt in the Ch11 QTL region is the only gene that is differentially expressed between DS and LEW kidneys. Figure 7A and B show the effects of oral administration of the COMT inhibitor, 3,5-dinitrocatechol, on SBP, DBP and PP throughout the study period in the DS and LEW rats, respectively. No significant differences in BP values over time were observed between the COMT inhibitor-treated group and the control group in either DS (by MANOVA; p= 0.37, 0.21 and 0.15 for SBP, DBP and PP, respectively) or LEW rats (by MANOVA; p= 0.38, 0.26 and 0.56 for SBP, DBP and PP, respectively).
Effects of COMT Inhibitors on BP Levels
Discussion
Recently, mice with disrupted Comt have been reported to be resistant to salt-induced hypertension (10) . Previously, we noted that the expression levels of Comt mRNA in DS kidneys were lower than those in LEW kidneys (4) . Thus, the present study was undertaken to investigate the hypothesis that the reduced expression of Comt mRNA in DS kidneys is a genetic compensatory mechanism to prevent further aggravation of salt-sensitive hypertension in DS rats.
Although QTL analysis indicated that the Comt locus was a suggestive QTL for PP and Comt was the only one gene differentially expressed between DS and LEW rats in this chromosomal region, COMT inhibitors had no significant effects on BP in either DS or LEW rats. The dose of 3,5-dinitrocatechol used in our study was 30 mg/kg, which was higher than that in the earlier study where its inhibitory effect on COMT activity as well as serum formation of 3-O-methyldopa was demonstrated in rats at an oral dose of 3 mg/kg (17) . It is likely that inhibition of COMT in the whole body by oral administration of the COMT inhibitor does not mimic the tissue-specific differential expression of COMT in DS rats. However, these pharmacological experiments strongly suggest that Comt is not the gene contributing to BP regulation in DS rats.
Fig. 7. Effect of COMT inhibitor on blood pressure (BP) levels in DS and LEW rats. Comparisons of BP values as determined by radiotelemetry between the control ( ) and the COMT inhibitor-treated groups (▲) in the DS (A) and LEW rats (B)
We were not able to identify other intriguing candidate genes in this Ch11 region based on microarray analyses, which mainly focused on protein-coding genes. Similar situations have been observed in the genetic analyses of spontaneously hypertensive rats, another prevalently used genetic model for hypertension (19) . The concept of a gene is now being re-evaluated (20) . Large transcriptional surveys have indicated that more than half of transcripts are non-coding (21, 22) . The genome is now considered to be full of overlapping transcripts (20) . Moreover, protein-coding sequences are now considered to have no clear beginning or end (23, 24) . To advance our understanding of polygenic diseases, including hypertension, we need to understand the total genomic function and the RNA world.
In conclusion, the reduced expression of Comt mRNA in DS kidneys appears to be genetically determined by the polymorphism in 3′-UTR through mRNA stability. However, this reduced expression of COMT in DS rats does not seem to contribute to salt-sensitive hypertension or salt resistance. The true gene contributing to pulse pressure in this Comt locus remains to be determined. Further studies on non-coding RNA will be required to clarify all of the genes contributing to salt-sensitive hypertension in DS rats.
